Orca Bio

Bringing Precision to Life

Menlo Park, United States · Founded 2016 · $567.0M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$567.0M
Last Round
$250.0M Series FDec 2025
Rounds
3

About

Orca Bio is a late-stage biotechnology company developing high-precision allogeneic T-cell immunotherapies for the treatment of cancer and autoimmune diseases. Its lead program, Orca-T, is designed to harness regulatory T cells to deliver durable remission with fewer risks than conventional stem cell transplants. The company has received FDA Priority Review for its Biologics License Application and completed a $250M aggregate financing in preparation for potential commercialization.

Summary

Orca Bio is a Biotech company based in Menlo Park, United States, founded in 2016. It has raised $567.0M in total across 3 rounds, most recently a $250.0M Series F round in Dec 2025. Investors include Lightspeed VP.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series FSeries FDec 2025
$250.0M

Sign up to see all 3 rounds

Series D through Series F — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Orca Bio on Indexed.vc
<a href="https://indexed.vc/companies/orca-bio"><img src="https://indexed.vc/api/badge/company/orca-bio" alt="Orca Bio on Indexed.vc" width="260" height="76" /></a>